Clinical Trial Update: Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

View source ↗

Summary

This clinical trial update describes the use of a live tumor diagnostic platform to evaluate immune checkpoint inhibitor responses across multiple solid tumors.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Colorectal Cancer
• Endometrial Cancer
• Esophageal Cancer
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma
• Triple-negative Breast Cancer
• Urothelial Carcinoma of the Bladder

Snippet

Sponsor: Mayo Clinic | Conditions: Early Stage Triple-Negative Breast Carcinoma, Metastatic Bladder Urothelial Carcinoma | Status: RECRUITING